Please login to the form below

Not currently logged in
Email:
Password:

Insmed appoints FDA's Dr Eugene Sullivan

He joinsthe US biopharmaceutical firm as its chief medical officer

US biopharmaceutical company Insmed has appointed former deputy director of the FDA Dr Eugene Sullivan to be its new chief medical and scientific officer.

Dr Sullivan was most recently vice president of global regulatory affairs at AstraZeneca and prior to that, during a career that has so far spanned more than 20 years focusing on pulmonary and orphan diseases, served at United Therapeutics.

He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.

In his new role Dr Sullivan will report to Will Lewis, president and chief executive officer, who said: “Gene is actively involved as an author, lecturer and advisor on medical and regulatory matters affecting orphan drugs and pulmonary diseases.

“His experience will provide new insight and valuable perspective as we advance Arikayce, INS1009 and our other pipeline candidates while building Insmed into a leading biopharmaceutical company.”

30th March 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics